Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis (clinicaltrials.gov) - Sep 10, 2026 - P4 | N=50 | Not yet recruiting | Sponsor: Istituto Giannina Gaslini
New P4 trial • Cystic Fibrosis • Genetic Disorders • Immunology • Pulmonary Disease • Respiratory Diseases
|